Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Médunik Canada has retained the services of Innomar, a leading specialty pharmaceutical service and patient support program provider, for the distribution of Ruzurgi® and management of its UnikAccess Patient Support Program.
Lead Product(s): Amifampridine Phosphate
Therapeutic Area: Immunology Product Name: Ruzurgi
Highest Development Status: ApprovedProduct Type: Small molecule
Recipient: MEDUNIK CANADA
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable September 25, 2020